Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

921 recalls · Class II, newest first

Class II · Moderate risk

Briviact (brivaracetam)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 50474-570-66 D-0591-2021
Class II · Moderate risk

VIMPAT (lacosamide)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 0131-2480-35 D-0590-2021
Class II · Moderate risk

VIMPAT (lacosamide)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. D-0589-2021
Class II · Moderate risk

Sulindac Tablets

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 42806-011-01 D-0582-2021
Class II · Moderate risk

Balziva 28 Day

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 0555-9034-58 D-0579-2021
Class II · Moderate risk

Proair HFA

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 59310-579-22 D-0573-2021
Class II · Moderate risk

Trokendi XR

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 17772-103-30 D-0570-2021

Recalls by year